Linde stock
LINNASDAQLinde plc, Basic MaterialsISIN IE000S9YS762
66Score 66 out of 100, Neutral
Price and trend
69 / 100
Price history
+22% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 5.3% above it.
Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 60).
The price is 4.4% below its 52-week high. Largest decline in 20 years: 52% (June 2008 to November 2008).
Chart figures for advanced users
- SMA 50$489.32
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$496.32
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)60
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$389.38
- The lowest closing price of the last twelve months.
- Resistance$546.64
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Linde plc belongs to the Chemicals (Specialty) industry (United Kingdom) and, with a market value of $239.87B, is the largest of 108 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $33.99B (up 3% year on year) and earnings of $6.9B (up 5.1%).
- For fiscal 2026, analysts expect on average revenue of $36.53B (up 7.5%) and adjusted earnings per share of $17.91 (up 8.9%).
Show more
- MEQIRI Score 66 out of 100 (Neutral): rank 129 of 467 in Basic Materials, median 58.
- The P/E is 34.5 (Chemicals (Specialty) median 24.4, own median of recent years 33.9).
- Our model puts fair value at $412.56, with the price 28% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Reliable dividendNo dividend cut for over 34 years.
- Earnings per share growingUp 25.3% a year since 2020.Growth 66
- Share buybacksShare count down 11% since 2020.
Weaknesses
- Above fair valuePrice 28% above the fair value of $412.56.Valuation 30
Its standout strengths are fundamentals and stability, while capital allocation and valuation hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamentals are strong, with stable profits.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among the 100 largest stocks.
From 2016 to 2025, 7 in 100 such stocks fell 30% or more within a year, against a group average of 9 in 100.
What drives the risk
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
What lowers it
- calm price action
- price near its 52-week high
- solid fundamentals
Valuation
Valuation signal
Significantly overvaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $343.80 and expensive above $515.70 (uncertainty low, based on the price swings of the past year).
The two parts of the fair value come to $456.21 (cash-flow model) and $368.90 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $371.93, at 7.8% it would be $473.72.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (24.4).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 8.2% on the twelve months before. Revenue has grown solidly since 2006, at about 8% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 38%, operating 27%, net 20%.
Debt & balance sheet
latest quarterThe balance sheet is solid, with moderate debt and comfortable interest coverage.
Earnings
- Next earnings
- 4 Feb 2027in 84 days
- Last reported
- 29 Oct 2026EPS reported $4.59 (expected $4.52)in line with expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $17.91+0.2%
- Revenue
- $36.53B+0.6%
- Earnings per share
- $19.54−0.3%
- Revenue
- $38.21B+0.3%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook lowered
Share price after the results: +1.2%Linde now expects only 5% to 7% EPS growth in the fourth quarter versus 9% in the third quarter, and keeps its cautious full-year guidance of $17.82 to $17.92 unchanged, assuming no economic improvement.
“The full year guide of $17.82 to $17.92 simply rolls the fourth quarter into the year-to-date actual.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 29 Oct 2026 (fiscal Q3 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
One insider bought on the open market in the last 6 months, $47,912 in total. 3 insiders sold, $52.75M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
Partial trades from one filing are shown in one row, with the average price.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Linde
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 66
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next smaller companies by market value
- L'Air LiquideAI.PA $136.09B63
- EcolabECL $86.34B70
- Sherwin-WilliamsSHW $85.95B68
- Air Products and ChemicalsAPD $70.19B47
- GivaudanGIVN.SW $45.43B73
- SikaSIKA.SW $37.55B68
- Wanhua Chemical Group600309.SS $32.8B60
- dsm-firmenichDSFIR.AS $28.85B57
ETFs that hold Linde
Held by 137 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares S&P 500 Materials Sector UCITS ETF2B7B | 21.13% | 0.15% | €180.37M |
| State Street SPDR S&P U.S. Materials Select Sector UCITS ETF (Acc)ZPDM | 20.72% | 0.15% | €52.49M |
| Xtrackers MSCI World Materials UCITS ETF 1CXDWM | 8.31% | 0.25% | €715.95M |
Show 5 more
| Amundi Global Hydrogen UCITS ETF AccAMEE | 6.89% | 0.45% | €201.78M |
| L&G Hydrogen Economy UCITS ETF USDHTMW | 5.06% | 0.49% | €394.28M |
| Global X S&P 500 Covered Call UCITS ETF IncXY7D | 4.80% | 0.45% | €203.27M |
| Invesco Global Active ESG Equity UCITS ETF USD AccIQSA | 1.60% | 0.30% | €3.12B |
| iShares Dow Jones Global Leaders Screened UCITS ETF USD (Acc)IUSL | 1.21% | 0.60% | €2.02B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 17 Jul 2026)
- Valuation signal Overvalued since 10 Nov 2026, previously Fairly valued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.